3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Recruiting
2
Terminated
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Conditions
Prostatic Neoplasms
32
Brain Neoplasms
21
Carcinoma, Non-Small-Cell Lung
19
Neoplasm Metastasis
17
Lung Neoplasms
15
Carcinoma, Hepatocellular
13
Breast Neoplasms
10
Pancreatic Neoplasms
9
Melanoma
9
Carcinoma, Renal Cell
9
Neoplasms
7
Colorectal Neoplasms
7
Spinal Cord Neoplasms
3
Small Cell Lung Carcinoma
3
Prostate Cancer Metastatic
3
Nasopharyngeal Carcinoma
3
Kidney Neoplasms
3
Adenocarcinoma
3
Urinary Bladder Neoplasms
2
Unresectable Locally Recurrent Rectal Cancer
2
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Radiation Injuries
2
Osteosarcoma
2
Oligometastatic Prostate Cancer
2
Neuroma, Acoustic
2
Neoplasms by Site
2
Klatskin Tumor
2
Head and Neck Neoplasms
2
Interventions
Cyclophosphamide
8
fludarabine
6
cabozantinib
5
Temozolomide
4
Doxorubicin
4
Zoledronic Acid
3
X-Rays
3
Vincristine
3
Methotrexate
3
Ifosfamide
3
Gemcitabine
3
Cisplatin
3
irinotecan sucrosofate
2
atezolizumab
2
Surgical Procedures, Operative
2
Sunitinib
2
Specimen Handling
2
Radiosurgery
2
Phantoms, Imaging
2
Mesna
2
Magnetic Resonance Spectroscopy
2
Irinotecan
2
Eflornithine
2
Disulfiram
2
Biopsy
2
vactosertib
1
trilaciclib
1
trametinib
1
talazoparib
1
surufatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Osteosarcoma
×
Radiosurgery
×
Clear all
NCT06492954
2026-03-02
AflacST2301
Emory University
Phase 1
Recruiting
12 enrolled
NCT06114225
2023-11-02
PROMIS
Ruijin Hospital
Phase 2
Recruiting
43 enrolled